1.30
-0.01(-0.76%)
Currency In USD
| Previous Close | 1.31 |
| Open | 1.33 |
| Day High | 1.36 |
| Day Low | 1.29 |
| 52-Week High | 3.66 |
| 52-Week Low | 1.18 |
| Volume | 11,959 |
| Average Volume | 60,801 |
| Market Cap | 13.85M |
| PE | -3.51 |
| EPS | -0.37 |
| Moving Average 50 Days | 1.56 |
| Moving Average 200 Days | 2.18 |
| Change | -0.01 |
If you invested $1000 in NEXGEL, Inc. (NXGL) since IPO date, it would be worth $369.32 as of February 15, 2026 at a share price of $1.3. Whereas If you bought $1000 worth of NEXGEL, Inc. (NXGL) shares 3 years ago, it would be worth $872.48 as of February 15, 2026 at a share price of $1.3.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
NEXGEL Announces Financing of $1.797 Million Relating to an Acquisition Targeted to Close in the First Quarter of 2026, Subject to the Completion of Due Diligence
GlobeNewswire Inc.
Feb 10, 2026 2:00 PM GMT
LANGHORNE, Pa., Feb. 10, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogel products
NexGelRx Receives Additional Investment from Eric Gruntfest of Diesis Holdings, LLC and Appoints Him as Board Observer and Strategic Advisor
GlobeNewswire Inc.
Dec 16, 2025 1:00 PM GMT
LANGHORNE, Pa., Dec. 16, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogel products
NEXGEL Announces Spin-Off of Drug Delivery Program into NexGelRx
GlobeNewswire Inc.
Dec 11, 2025 1:00 PM GMT
NEXGEL shareholders will receive a non-dilutive 19.99% equity interest in NexGelRx up to $8 million of capital investment in spin-off NEXGEL will also receive a 5% global royalty in perpetuity on products sold using its drug delivery technology LANGH